This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Byington, C. L.
Right arrow Articles by Pavia, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Byington, C. L.
Right arrow Articles by Pavia, A. T.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Escherichia coli and Other Gram...

PEDIATRICS Vol. 111 No. 5 May 2003, pp. 964-968

Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens

Carrie L. Byington, MD*,{ddagger}, Kristine K. Rittichier, MD§, Kathlene E. Bassett, MD§, Heidi Castillo, MD*, Tiffany S. Glasgow, MD*, Judy Daly, PhD and Andrew T. Pavia, MD{ddagger}

* University of Utah Divisions of General Pediatrics
{ddagger} Pediatric Infectious Diseases
§ Pediatric Emergency Medicine
PCMC Microbiology Laboratory, Salt Lake City, Utah

--> Background. Intrapartum antibiotic prophylaxis against group B Streptococcus (GBS) has reduced the occurrence of serious bacterial infections (SBI) in young infants caused by GBS. Recommendations for initial antibiotic therapy for the febrile infant 1 to 90 days old were developed when infections with GBS were common and antibiotic resistance was rare.

Objective. To document the pathogens responsible for SBI in recent years in febrile infants 1 to 90 days old and the antibiotic susceptibility of these organisms.

Methods. The results of bacterial cultures from infants 1 to 90 days old evaluated for fever at Primary Children’s Medical Center in Salt Lake City, Utah, between July 1999 and April 2002 were analyzed. Antibiotic susceptibility profiles were collected and patient records were reviewed to determine if initial antibiotic therapy was changed following the identification of the organism.

Results. Of 1298 febrile infants enrolled from the Primary Children’s Medical Center emergency department, 105 (8%) had SBI. The mean age of the infants with SBI was 39 days (range 2–82 days) and 2 (2%) were <7 days. SBI included urinary tract infection (UTI; 67%), bacteremia (16%), bacteremia and UTI (6%), bacteremia and meningitis (5%), meningitis (2%), abscess (2%), meningitis and UTI (1%), and meningitis and gastroenteritis (1%). Eighty-three (79%) of 105 episodes of SBI were caused by Gram-negative bacteria, including 92% of UTI, 54% of bacteremia, and 44% of meningitis cases. The most common pathogen was Escherichia coli (61%). Other Gram-negative pathogens were responsible for 19% of SBI. Staphylococcus aureus was the most common Gram-positive pathogen, causing 8% of SBI. GBS accounted for 6% of SBI.

Of the 105 pathogens, 56 (53%) were resistant to ampicillin. Of the pathogens causing meningitis, UTI, and bacteremia, 78%, 53%, and 50%, respectively, were resistant to ampicillin. Antibiotic therapy was changed in 54% of cases of SBI following identification of the organism.

Conclusions. In Utah, ampicillin-resistant Gram-negative bacteria are the most common cause of SBI in febrile infants <90 days old. This finding impacts antibiotic selection, especially in cases of meningitis. Local surveillance of pathogens and antibiotic susceptibility patterns is critical to determine appropriate antibiotic therapy.

Key Words: fever • infant • serious bacterial infection • ampicillin • antibiotic resistance

Abbreviations: GBS, group B Streptococcus • SBI, serious bacterial infection • UTI, urinary tract infection • ESBL, extended spectrum ß-lactamases • ampC, ampC ß-lactamases • PCMC, Primary Children’s Medical Center • ED, emergency department • CSF, cerebrospinal fluid


Received for publication Aug 28, 2002; Accepted Nov 12, 2002.




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
A. R. Schroeder, T. B. Newman, R. C. Wasserman, S. A. Finch, and R. H. Pantell
Choice of Urine Collection Methods for the Diagnosis of Urinary Tract Infection in Young, Febrile Infants
Arch Pediatr Adolesc Med, October 1, 2005; 159(10): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. S. Glasgow, P. C. Young, J. Wallin, C. Kwok, G. Stoddard, S. Firth, M. Samore, and C. L. Byington
Association of Intrapartum Antibiotic Exposure and Late-Onset Serious Bacterial Infections in Infants
Pediatrics, September 1, 2005; 116(3): 696 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. Starner, B. Agerberth, G. H. Gudmundsson, and P. B. McCray Jr.
Expression and Activity of {beta}-Defensins and LL-37 in the Developing Human Lung
J. Immunol., February 1, 2005; 174(3): 1608 - 1615.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
A. C. Rentz, M. H. Samore, G. J. Stoddard, R. G. Faix, and C. L. Byington
Risk Factors Associated With Ampicillin-Resistant Infection in Newborns in the Era of Group B Streptococcal Prophylaxis
Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 556 - 560.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. L. Byington, F. R. Enriquez, C. Hoff, R. Tuohy, E. W. Taggart, D. R. Hillyard, K. C. Carroll, and J. C. Christenson
Serious Bacterial Infections in Febrile Infants 1 to 90 Days Old With and Without Viral Infections
Pediatrics, June 1, 2004; 113(6): 1662 - 1666.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
E. Parravicini
GBS Maternal Prophylaxis Does Not Increase Non-GBS Infections in Newborns
AAP Grand Rounds, January 1, 2004; 11(1): 2 - 3.
[Full Text] [PDF]